Ardent Health Partners Inc
For the period ended Dec 31, 2024. Filed Feb 27, 2025.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2024 · Filed Feb 27, 2025
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Signatures
Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
| ARDENT HEALTH PARTNERS, INC. | |||
| Date: | February 27, 2025 | By: | /s/ Martin J. Bonick |
|---|---|---|---|
| Martin J. Bonick | |||
| President and Chief Executive Officer | |||
Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the Registrant and in the capacities and on the dates indicated.
| Signature | Title | Date |
|---|---|---|
| /s/ Martin J. Bonick | President and Chief Executive Officer, Director | February 27, 2025 |
| Martin J. Bonick | (Principal Executive Officer) | |
| /s/ Alfred Lumsdaine | Chief Financial Officer | February 27, 2025 |
| Alfred Lumsdaine | (Principal Financial Officer) | |
| /s/ David Byers | Senior Vice President, Chief Accounting Officer | February 27, 2025 |
| David Byers | (Principal Accounting Officer) | |
| /s/ Mark Sotir | Director | February 27, 2025 |
| Mark Sotir | ||
| /s/ Peter Bulgarelli | Director | February 27, 2025 |
| Peter Bulgarelli | ||
| /s/ Peter Bynoe | Director | February 27, 2025 |
| Peter Bynoe | ||
| /s/ Suzanne Campion | Director | February 27, 2025 |
| Suzanne Campion | ||
| /s/ William Goodyear | Director | February 27, 2025 |
| William Goodyear | ||
| /s/ Ellen Havdala | Director | February 27, 2025 |
| Ellen Havdala | ||
| /s/ Edmondo Robinson | Director | February 27, 2025 |
| Edmondo Robinson | ||
| /s/ Rahul Sen | Director | February 27, 2025 |
| Rahul Sen | ||
| /s/ Rob Webb | Director | February 27, 2025 |
| Rob Webb | ||
INDEX TO CONSOLIDATED FINANCIAL STATEMENTS
| Page | |
| Report of Independent Registered Public Accounting Firm | F-2 |
|---|---|
| Consolidated Financial Statements: | |
| Consolidated Income Statements for the Years Ended December 31, 2024, 2023 and 2022 | F-5 |
| Consolidated Comprehensive Income Statements for the Years Ended December 31, 2024, 2023 and 2022 | F-6 |
| Consolidated Balance Sheets for the Years Ended December 31, 2024 and 2023 | F-7 |
| Consolidated Statements of Changes in Equity for the Years Ended December 31, 2024, 2023 and 2022 | F-8 |
| Consolidated Statements of Cash Flows for the Years Ended December 31, 2024, 2023 and 2022 | F-9 |
| Notes to Consolidated Financial Statements | F-11 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.